Barely Significant
← all excerpts

Pharmacologic modulation of intracellular Na<sup>+</sup> concentration with ranolazine impacts inflammatory response in humans and mice.

Proc Natl Acad Sci U S A · 2022 · PMC9303949 · PMID 35858345

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

showed a trendno p-value reported
However, the survival curve of ranolazine showed a trend for an overall reduction of cardiovascular events after one and a half years, similar to the survival curves in the CANTOS trial at this time.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.